FDAnews Drug Daily Bulletin
Nov. 13, 2012 | Vol. 9 No. 223
Pharma Blog Watch
Glaxo Employee Blows Whistle on Drug Promotions (Pharmalot Blog)
In a ruling issued last week, an Association for the British Pharmaceutical Industry panel found GlaxoSmithKline violated the code of conduct three different ways in connection with a promotional push for Revolade, blogger Ed Silverman writes. “The unnamed Glaxo employee complained that a sales rep had promoted Revolade for myeloid fibrosis to a National Health Service consultant through e-mails and meetings,” Silverman writes. “And the panel ruled that the communications, which referred to both maladies involving a particular patient, could have been misconstrued and the rep should have known better.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.